A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder

BACKGROUND: Extended-release (XR) naltrexone can prevent relapse to opioid use disorder following detoxification. However, one of the barriers to initiating XR-naltrexone is the recommendation for a 7–10-day period of abstinence from opioids prior to the first dose. OBJECTIVES: The current study eva...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Drug Alcohol Abuse
Hoofdauteurs: Sibai, Mohammad, Mishlen, Kaitlyn, Nunes, Edward V., Levin, Frances R., Mariani, John J., Bisaga, Adam
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7260104/
https://ncbi.nlm.nih.gov/pubmed/31860366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2019.1700265
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items